A multi-criteria decision analysis framework that prioritizes economic policy to enhance value based health care during the COVID-19 pandemic

Abstract

ObjectiveTo investigate pandemic impacts on Value-Based Health Care (VBHC) globally, using multi-criteria decision analysis (MCDA) to address challenges through prioritizing economic policies.MethodsPreferred Reporting Items for Systematic reviews and Meta Analyses extension for Scoping-Reviews (PRISMA-ScR), PUBMED, Medline, and google-scholar were used to analyze pandemic impacts on VBHC domains. MCDA prioritized economic policies, utilizing the value-measurement model with additive-weighted scores. The criteria weighting-method used direct-rating, ranking and robust deliberation by four experts to priority rank economic policies for each VBHC domain.ResultsCOVID-19 impacted on all VBHC domains: Integrated Practice Units, outcome and cost measurement, Value-Based Reimbursement, Information Technology (IT), regional systems integration, geography of care and VBHC policy and institutions. There were changes in patient complexity, service delivery, activity, models of care, pricing, costs, IT, quality, and health status. COVID-19 pricing impacts included increased capacity costs, Personal Protective Equipment costs, cost per patient, service delivery changes, and telehealth costs. A median of 37% of patients globally avoided care, negatively impacting on diabetes, venous thromboembolism, Parkinson’s disease, kidney disease, myocardial infarction, stroke, and cancer patients. A consequence is inaccurate assessments of health status, underestimated projected health needs, and costs for risk-adjustment, impacting health services. Innovations include telehealth and changing service redesign. New care models include state-wide ICU-COVID Models of Care, Telehealth-Inpatient Physician Services, COVID-linked pathology testing, and increased Hospital in the Home. Artificial Intelligence innovations involved patient-screening, triage, risk-evaluation, care assessment, pathways, and laboratories. Risk-adjustment challenges impacted on Value-Based Reimbursement and patient risk-stratification. MCDA prioritized economic policies, including healthcare system performance, healthcare demand and supply, risk-adjustment, planning and market mechanisms, economic evaluation of healthcare, economic sustainability initiatives, and health determinants.ConclusionCOVID-19 demonstrated the limits of health systems globally, with increasing costs and limited budgets. The economic strategies identified can enhance VBHC globally.